Medindia

X

BioMarin Initiates Phase 1 Clinical Study of BMN 195 for Duchenne Muscular Dystrophy

Monday, January 11, 2010 General News J E 4
Advertisement

Contacts:

Investors

Media

Eugenia Shen

Susan Berg

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 506-6570

(415) 506-6594

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Jennerex Appoints Dr. Hoyoung Huh to Its Board of ...
S
Austin Clinical Research Center Tests Investigatio...